Have a personal or library account? Click to login
Probable warm autoimmune hemolytic anemia proceeding the administration of the Pfizer mRNA COVID-19 vaccine Cover

Probable warm autoimmune hemolytic anemia proceeding the administration of the Pfizer mRNA COVID-19 vaccine

Immunohematology
Volume 38 (2022): Issue 3 (September 2022)
By: Kingsley C. Nnawuba,  Benjamin M. Boral and  Robert W. Donnell  
Paid access
|Sep 2022

References

  1. Bennet BM, Wolf J, Laureano R, Sellers RS. Review of current vaccine development strategies to prevent coronavirus disease 2019 (COVID-19). Toxicol Pathol 2020;48:800–9.
    Search in Google ScholarBack to article
  2. Brito S, Ferreira N, Mateus S, et al. A case of autoimmune hemolytic anemia following COVID-19 messenger ribonucleic acid vaccination. Cureus 2021;13:e15035.
    Search in Google ScholarBack to article
  3. Ciotti M, Cicozzi M, Terrinoni A, Jiang W-C, Wang C-B, Bernardini S. The COVID-19 pandemic. Crit Rev Clin Lab Sci 2020;57: 365–8.
    Search in Google ScholarBack to article
DOI: https://doi.org/10.21307/immunohematology-2022-051 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Journal RSS Feed
Language: English
Page range: 106 - 107
Published on: Sep 22, 2022
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
Medicine,
Clinical medicine,
Laboratory medicine

© 2022 Kingsley C. Nnawuba, Benjamin M. Boral, Robert W. Donnell, published by American National Red Cross
This work is licensed under the Creative Commons License.

Previous articleVolume 38 (2022): Issue 3 (September 2022)